logo
Twitter
Discord
Email
logo
Clarivate Plc

Clarivate Plc

NYSE•CLVT
CEO: Mr. Jonathan M. Collins
Sector: Technology
Industry: Information Technology Services
Listing Date: 2018-10-29
Clarivate Plc operates as an information services provider in the Americas, the Middle East, Africa, Europe, and the Asia Pacific. It operates through three segments: Academia & Government, Life Sciences & Healthcare, and Intellectual Property. The company offers Web of Science and InCites, that analyzes and explores the academic research landscape and manages research information; ProQuest One and Ebook Central that provides comprehensive content collections to institutions in a cost-effective manner; and Alma and Polaris, that manages academic resources and services, connect users, and support research publications. It also provides Patent and Trademark Renewals, that supports paralegal and admin tasks throughout the patent and trademark protection and maintenance process; CompuMark and Derwent, that supports critical decisions around patent and trademark protection, risk, and value creation throughout the innovation and brand lifecycle; IPFolio and Foundation IP that creates a structured environment for the protection and management of global patent and trademark assets. In addition, the company offers Cortellis Competitive Intelligence and Cortellis Drug Discovery Intelligence, that supports the development of new drugs and medical devices from discovery to clinical trials; Cortellis Regulatory Intelligence and OFF-X to monitor drug safety issues and adhere to regulatory protocols; Real World Data and Optimize that inform commercial launch strategy and set pricing for optimal reimbursement. It serves corporations, universities, law firms, government agencies, public libraries, and other professional services organizations. The company was formerly known as Clarivate Analytics Plc and changed its name to Clarivate Plc in May 2020. Clarivate Plc was founded in 1864 and is headquartered in London, the United Kingdom.
Contact Information
70 St. Mary Axe, London, EC3A 8BE, United Kingdom
44-20-7433-4000
www.clarivate.com
Market Cap
$2.29B
P/E (TTM)
-5.8
35
Dividend Yield
--
52W High
$5.88
52W Low
$3.04
52W Range
15%
1.6
F-Score
Modified Piotroski Analysis
Based on 8-year fundamentals
Weak • 1.6 / 9 points
Scoring Range (0-9)
8-9: Excellent Value
6-7: Strong Fundamentals
4-5: Average Quality
0-3: Weak Performance
Data Period: 2017-2024

Financial Dashboard

Q3 2025 Data

Revenue

$623.10M+0.14%
4-Quarter Trend

EPS

-$0.04-53.67%
4-Quarter Trend

FCF

$115.50M-8.55%
4-Quarter Trend

2025 Q3 Earnings Highlights

Key Highlights

Operating Income Swing Positive Operating income $30.1M YTD 2025 versus $(213.3)M loss in 2024; driven by lower impairments. (17 words)
Net Loss Significantly Narrows Net loss attributable to ordinary shares $204.2M YTD 2025, substantially improved from $476.2M loss prior year. (18 words)
Organic ACV Growth Steady Organic Annualized Contract Value grew 1.6% versus September 2024, reflecting pricing increases across subscription base. (17 words)
Impairment Charges Eliminated Goodwill and intangible asset impairments totaled $0M YTD 2025, compared to $316.6M charge recognized in 2024. (17 words)

Risk Factors

Total Revenues Declining Total revenues down 2.9% YTD to $1,838.2M, impacted by divestitures and product group wind-downs across segments. (18 words)
Restructuring Costs Increase Restructuring and other impairments rose to $45.9M YTD 2025, primarily due to ongoing Value Creation Plan execution. (17 words)
Total ACV Decreases Total ACV declined 3.4% to $1,542.7M due to ScholarOne divestiture and wind-down of certain product groups. (17 words)
Legal Proceedings Exposure Engaged in ongoing securities class action litigation; ultimate resolution and financial impact remain uncertain at this stage. (18 words)

Outlook

Liquidity Position Strong Cash on hand $318.7M; $768.5M available borrowing capacity under revolving credit facility as of September 30, 2025. (19 words)
Share Repurchase Program Active $350.5M availability remains under the $500.0M repurchase authorization valid through December 31, 2026. (17 words)
Value Creation Plan Progress Value Creation Plan restructuring expected to be substantially completed by the end of 2025, focusing on cost optimization. (18 words)
Capital Needs Forecasted Forecasts indicate operating cash flow and capacity adequate for debt service, capital expenditures, and business plans for 12 months. (20 words)

Peer Comparison

Revenue (TTM)

DXC Technology CompanyDXC
$12.71B
-4.1%
Concentrix CorporationCNXC
$9.72B
+3.4%
ASGN IncorporatedASGN
$3.99B
-4.9%

Gross Margin (Latest Quarter)

Clarivate PlcCLVT
65.0%
-1.3 pp
Pagaya Technologies Ltd.PGY
41.0%
+0.7 pp
C3.ai, Inc.AI
37.6%
-22.2 pp

Key Metrics

Symbol
Market Cap
P/E (TTM)
ROE (TTM)
Debt to Assets
GLOB$2.69B24.15.6%15.8%
FORTY$2.45B31.111.4%21.4%
DXC$2.33B6.112.0%34.6%

Long-Term Trends

Last 4 Quarters
Revenue
Net Income
Operating Cash Flow
4Q Revenue CAGR
-2.0%
Flat Growth
4Q Net Income CAGR
N/M
Profitability Shift
Cash Flow Stability
100%
Strong Cash Flow

Research & Insights

Reports
All Years
  • Form 10-Q - Q3 2025

    Period End: Sep 30, 2025|Filed: Oct 29, 2025|
    Revenue: $623.10M+0.1%
    |
    EPS: $-0.04-53.7%
    Miss
  • Form 10-Q - Q2 2025

    Period End: Jun 30, 2025|Filed: Jul 30, 2025|
    Revenue: $621.40M-4.4%
    |
    EPS: $-0.11-76.1%
    Miss
  • Form 10-Q - Q1 2025

    Period End: Mar 31, 2025|Filed: Apr 29, 2025|
    Revenue: $593.70M-4.4%
    |
    EPS: $-0.15+36.4%
    Miss
  • Form 10-K - FY 2024

    Period End: Dec 31, 2024|Filed: Feb 19, 2025|
    Revenue: $2.56B-2.7%
    |
    EPS: $-0.96+34.7%
    Miss
  • Form 10-Q - Q3 2024

    Period End: Sep 30, 2024|Filed: Nov 6, 2024|
    Revenue: $622.20M-3.9%
    |
    EPS: $-0.09+831.6%
    Miss
  • Form 10-Q - Q2 2024

    Period End: Jun 30, 2024|Filed: Aug 6, 2024|
    Revenue: $650.30M-2.8%
    |
    EPS: $-0.46+155.6%
    Miss
  • Form 10-Q - Q1 2024

    Period End: Mar 31, 2024|Filed: May 8, 2024|
    Revenue: $621.20M-1.3%
    |
    EPS: $-0.11-400.5%
    Miss
  • Form 10-K - FY 2023

    Period End: Dec 31, 2023|Filed: Feb 27, 2024|
    Revenue: $2.63B-1.2%
    |
    EPS: $-1.47+76.5%
    Miss